Cabaletta Bio
-$0.23 (-2.49%) As of 1:37 PM UTC today
Why Robinhood?
You can buy or sell Cabaletta Bio and other stocks, options, and ETFs commission-free!
About CABA
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
CEO
Steven Nichtberger
Employees
34
Headquarters
Philadelphia, Pennsylvania
Founded
2017
CABA Key Statistics
Market Cap
240.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
135.29K
High Today
$9.22
Low Today
$9.02
Open Price
$9.22
Volume
1.66K
52 Week High
$16.38
52 Week Low
$6.72
CABA Earnings
-$0.65
-$0.43
-$0.22
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
-$0.41 per share